Viewing Study NCT04988269


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2026-01-01 @ 10:48 AM
Study NCT ID: NCT04988269
Status: COMPLETED
Last Update Posted: 2021-08-03
First Post: 2021-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessment of Diurnal Salivary Cortisol Production in COVID-19
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000086382', 'term': 'COVID-19'}, {'id': 'D000309', 'term': 'Adrenal Insufficiency'}, {'id': 'D000308', 'term': 'Adrenocortical Hyperfunction'}], 'ancestors': [{'id': 'D011024', 'term': 'Pneumonia, Viral'}, {'id': 'D011014', 'term': 'Pneumonia'}, {'id': 'D012141', 'term': 'Respiratory Tract Infections'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D018352', 'term': 'Coronavirus Infections'}, {'id': 'D003333', 'term': 'Coronaviridae Infections'}, {'id': 'D030341', 'term': 'Nidovirales Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}, {'id': 'D000307', 'term': 'Adrenal Gland Diseases'}, {'id': 'D004700', 'term': 'Endocrine System Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D001800', 'term': 'Blood Specimen Collection'}], 'ancestors': [{'id': 'D013048', 'term': 'Specimen Handling'}, {'id': 'D019411', 'term': 'Clinical Laboratory Techniques'}, {'id': 'D019937', 'term': 'Diagnostic Techniques and Procedures'}, {'id': 'D003933', 'term': 'Diagnosis'}, {'id': 'D011677', 'term': 'Punctures'}, {'id': 'D013514', 'term': 'Surgical Procedures, Operative'}, {'id': 'D008919', 'term': 'Investigative Techniques'}]}}, 'protocolSection': {'designModule': {'bioSpec': {'retention': 'SAMPLES_WITHOUT_DNA', 'description': 'Serum, plasma and saliva samples'}, 'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'CASE_CONTROL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 85}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-04-15', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2021-07', 'completionDateStruct': {'date': '2021-07-28', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2021-07-30', 'studyFirstSubmitDate': '2021-07-28', 'studyFirstSubmitQcDate': '2021-07-30', 'lastUpdatePostDateStruct': {'date': '2021-08-03', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2021-08-03', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2021-07-15', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Diurnal variation of cortisol levels in the saliva (mcg/dL)', 'timeFrame': 'One day', 'description': 'Saliva sampling was performed at 4 different time points during one day (08.00, 12.00, 18.00, 22.00).'}], 'secondaryOutcomes': [{'measure': 'Single hormone assessment of plasma ACTH levels (pg/mL)', 'timeFrame': 'One day', 'description': 'Blood sampling was performed on the day of Hospital admission at one time point'}, {'measure': 'Diurnal variation of dehydroepiandrosterone (DHEA) levels (pg/mL) in the saliva', 'timeFrame': 'One day', 'description': 'Saliva sampling was performed at 4 different time points during one day (08.00, 12.00, 18.00, 22.00).'}, {'measure': 'Single hormone assessment of plasma aldosterone levels (pmol/L)', 'timeFrame': 'One day', 'description': 'Blood sampling was performed on the day of Hospital admission at one time point'}, {'measure': 'Single hormone assessment of serum Interleukin-6 levels (IL-6) (pg/mL)', 'timeFrame': 'One day', 'description': 'Blood sampling was performed on the day of Hospital admission at one time point'}, {'measure': 'Single hormone assessment of serum C-reactive protein levels (CRP) (mg/L)', 'timeFrame': 'One Day', 'description': 'Blood sampling was performed on the day of Hospital admission at one time point'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['SARS-CoV-2 infection', 'Adrenal Cortex', 'Salivary Cortisol', 'Salivary DHEA', 'Aldosterone', 'ACTH', 'Interleukin 6', 'Circadian Rythm'], 'conditions': ['COVID-19', 'Adrenal Insufficiency', 'Adrenal Hyperfunction']}, 'referencesModule': {'references': [{'pmid': '35043384', 'type': 'DERIVED', 'citation': 'Yavropoulou MP, Filippa MG, Mantzou A, Ntziora F, Mylona M, Tektonidou MG, Vlachogiannis NI, Paraskevis D, Kaltsas GA, Chrousos GP, Sfikakis PP. Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations. Endocrine. 2022 Feb;75(2):317-327. doi: 10.1007/s12020-021-02968-8. Epub 2022 Jan 18.'}]}, 'descriptionModule': {'briefSummary': 'In the year of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic several studies have focused on the effect of the COVID-19 on the adrenal cortex, demonstrating conflicting results. Herein, researchers sought to investigate the adrenal response in patients with COVID-19by assessing the diurnal rhythm of salivary cortisol and the adrenal androgen dehydroepiandrosterone (DHEA), as well as the plasma levels of aldosterone and adrenocorticotropic hormone (ACTH) in consecutive patients before the possible therapeutic administration of dexamethasone. To elucidate the potential association between the magnitude of individual immune response and the adrenal cortex response we included serum measurements of interleukin - 6 (IL-6).', 'detailedDescription': "All adult consecutive patients that visited the emergency department of the LAIKO General Hospital of Athens from May to July 2021 due to confirmed COVID-19 and related symptomatology were eligible for the study.\n\nAge and gender matched healthy individuals without COVID-19 who had never been treated with GCs and fulfilled the exclusion criteria were also recruited from the Hospital's personnel and included in the analysis as Controls.\n\nBlood samples were obtained immediately upon admission for the measurements of ACTH, IL-6 and aldosterone, which were performed by electrochemiluminescence assays on the cobas e 801 immunoassay analysers (Roche Diagnostics GmbH). Salivary samples for free cortisol and DHEAS were obtained during the next day using the Salivette (Sarstedt, Nümbrecht, Germany) at different time points 0800, 12.00, 18.00, and 22.00. Within 24h after saliva collection the salivettes were centrifuged at 2400 g for 20 min in 4 °C and aliquots were stored at -80 °C and analyzed by an Immunochemiluminescence assay in a Roche COBAS E411 analyzer."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'Hospital based population. Patients with confirmed COVID-19', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria:\n\nAdult patients that visited the Emergency Department of LAIKO General Hospital of Athens, Greece from May to July 2021 due to confirmed COVID-19 and related symptomatology\n\nExclusion Criteria:\n\n(i) pre-existing hypoadrenalism or concurrent systemic glucocorticoid treatment (ii) patients with chronic kidney disease stage 3b and above, (iii) patients with advanced metastatic disease.'}, 'identificationModule': {'nctId': 'NCT04988269', 'briefTitle': 'Assessment of Diurnal Salivary Cortisol Production in COVID-19', 'organization': {'class': 'OTHER', 'fullName': 'National and Kapodistrian University of Athens'}, 'officialTitle': 'COVID-19, Interleukin - 6 and Diurnal Salivary Cortisol', 'orgStudyIdInfo': {'id': 'Ε.Σ 310'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'Patients (Cases)', 'description': 'Adult consecutive patients that visited the Emergency Department of LAIKO General Hospital of Athens, Greece from May to July 2021 due to confirmed COVID-19 and related symptomatology.\n\nBlood sampling on the day of admission (one time point) and saliva sampling at 4 different time points (0.800, 12.00, 18.00,22.00) the next day (all sampling in one day).', 'interventionNames': ['Diagnostic Test: Blood sampling', 'Diagnostic Test: Saliva sampling']}, {'label': 'Healthy Controls', 'description': 'Age and gender matched healthy individuals without COVID-19. Blood sampling (at day 1) and saliva sampling at different time points (0.800, 12.00, 18.00,22.00) the next day (all sampling in one day-day 2).', 'interventionNames': ['Diagnostic Test: Blood sampling', 'Diagnostic Test: Saliva sampling']}], 'interventions': [{'name': 'Blood sampling', 'type': 'DIAGNOSTIC_TEST', 'description': 'Assessment of circulating levels of plasma ACTH, plasma aldosterone and serum interleukin -6 levels at day 1', 'armGroupLabels': ['Healthy Controls', 'Patients (Cases)']}, {'name': 'Saliva sampling', 'type': 'DIAGNOSTIC_TEST', 'description': 'Assessment of diurnal variation of cortisol and DHEA levels in the saliva at 4 different time points during the day (0.800, 12.00, 18.00, 22.00) at day 2.', 'armGroupLabels': ['Healthy Controls', 'Patients (Cases)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '11527', 'city': 'Athens', 'country': 'Greece', 'facility': 'Medical School, National and Kapodistrian University of Athens', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}]}, 'ipdSharingStatementModule': {'infoTypes': ['STUDY_PROTOCOL', 'SAP', 'ICF'], 'timeFrame': 'From the day of publication and for 1 year.', 'ipdSharing': 'YES', 'description': 'all IPD that underlie results in a publication'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'National and Kapodistrian University of Athens', 'class': 'OTHER'}, 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Senior Endocrinology Consultant', 'investigatorFullName': 'Maria Yavropoulou', 'investigatorAffiliation': 'National and Kapodistrian University of Athens'}}}}